Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Average Rating of “Hold” from Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been given a consensus recommendation of “Hold” by the eleven analysts that are currently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $11.0625.

A number of research firms have commented on AVAH. Raymond James Financial reiterated an “outperform” rating and set a $13.00 target price on shares of Aveanna Healthcare in a research report on Friday, December 5th. BMO Capital Markets initiated coverage on Aveanna Healthcare in a research note on Thursday, November 13th. They set an “outperform” rating and a $11.00 price target for the company. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Royal Bank Of Canada increased their price objective on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research note on Thursday, January 15th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th.

Insider Buying and Selling

In other news, insider Edwin C. Reisz sold 60,769 shares of the business’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $438,144.49. Following the completion of the transaction, the insider directly owned 1,447,057 shares of the company’s stock, valued at $10,433,280.97. The trade was a 4.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jeff Shaner sold 173,225 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the completion of the sale, the chief executive officer owned 2,650,892 shares in the company, valued at $19,112,931.32. This represents a 6.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 998,595 shares of company stock valued at $7,567,770. 7.00% of the stock is owned by company insiders.

Institutional Trading of Aveanna Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in shares of Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after buying an additional 1,535,351 shares during the last quarter. Geode Capital Management LLC boosted its position in Aveanna Healthcare by 17.7% during the fourth quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock worth $15,110,000 after acquiring an additional 278,429 shares during the last quarter. AustralianSuper Pty Ltd purchased a new stake in Aveanna Healthcare in the 3rd quarter worth approximately $15,743,000. Nuveen LLC raised its holdings in Aveanna Healthcare by 135.9% in the 4th quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock valued at $12,838,000 after acquiring an additional 905,316 shares during the last quarter. Finally, State Street Corp raised its holdings in Aveanna Healthcare by 20.9% in the 4th quarter. State Street Corp now owns 1,483,265 shares of the company’s stock valued at $12,118,000 after acquiring an additional 256,392 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Trading Down 0.4%

Shares of Aveanna Healthcare stock opened at $7.23 on Monday. The company has a 50-day moving average of $8.14 and a two-hundred day moving average of $8.56. Aveanna Healthcare has a 12-month low of $3.67 and a 12-month high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market cap of $1.51 billion, a PE ratio of 20.08 and a beta of 2.07.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.